Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 6:26 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-24 | Payment of Exercise | 14,286 | $6.18 | $88,216.10 | (3%) 521.14K to 506.85K | |
| 30-Sep-24 6:15 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Sep-24 | Option Exercise | 6,000 | $1.06 | $6,360.00 | 1% 521.14K to 527.14K | |
| 30-Sep-24 6:15 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Sep-24 | Planned Option Sale | 6,000 | $7.00 | $42,004.80 | (1%) 527.14K to 521.14K | |
| 03-Sep-24 4:48 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 29-Aug-24 | Option Exercise | 6,000 | $1.06 | $6,360.00 | 1% 521.14K to 527.14K | |
| 03-Sep-24 4:48 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 29-Aug-24 | Planned Option Sale | 6,000 | $7.56 | $45,376.20 | (1%) 527.14K to 521.14K | |
| 29-Jul-24 6:16 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jul-24 | Option Exercise | 6,000 | $1.06 | $6,360.00 | 1% 535.46K to 541.46K | |
| 29-Jul-24 6:16 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jul-24 | Planned Option Sale | 6,000 | $8.13 | $48,809.40 | (1%) 541.46K to 535.46K | |
| 28-Jun-24 5:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Jun-24 | Option Exercise | 6,000 | $1.06 | $6,360.00 | 1% 535.46K to 541.46K | |
| 28-Jun-24 5:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Jun-24 | Planned Option Sale | 6,000 | $7.22 | $43,290.00 | (1%) 541.46K to 535.46K | |
| 03-Jun-24 6:31 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 30-May-24 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 535.46K to 538.46K | |
| 03-Jun-24 6:31 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 30-May-24 | Planned Option Sale | 3,000 | $8.77 | $26,325.00 | (< 1%) 538.46K to 535.46K | |
| 17-May-24 7:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-May-24 | Payment of Exercise | 9,998 | $10.01 | $100,080.00 | (2%) 543.23K to 533.23K | |
| 29-Apr-24 6:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Apr-24 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 543.23K to 546.23K | |
| 29-Apr-24 6:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Apr-24 | Planned Option Sale | 3,000 | $7.67 | $23,020.50 | (< 1%) 546.23K to 543.23K | |
| 25-Mar-24 6:39 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 21-Mar-24 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 1% 639.98K to 647.98K | |
| 25-Mar-24 6:39 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 21-Mar-24 | Planned Option Sale | 8,000 | $10.75 | $85,979.90 | (1%) 647.98K to 639.98K | |
| 23-Feb-24 7:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 22-Feb-24 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 1% 639.98K to 647.98K | |
| 23-Feb-24 7:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 22-Feb-24 | Planned Option Sale | 8,000 | $14.90 | $119,160.00 | (1%) 647.98K to 639.98K | |
| 16-Feb-24 7:58 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Feb-24 | Payment of Exercise | 5,379 | $12.43 | $66,861.00 | (< 1%) 645.36K to 639.98K | |
| 13-Feb-24 7:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Grant | 233,613 | -- | -- | 56% 414.55K to 648.16K | |
| 13-Feb-24 7:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Payment of Exercise | 2,800 | $10.09 | $28,252.00 | (< 1%) 648.16K to 645.36K | |
| 29-Jan-24 6:52 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jan-24 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 2% 414.55K to 422.55K | |
| 29-Jan-24 6:52 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jan-24 | Planned Option Sale | 8,000 | $10.35 | $82,761.60 | (2%) 422.55K to 414.55K | |
| 02-Jan-24 4:58 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Dec-23 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 2% 414.55K to 422.55K | |
| 02-Jan-24 4:58 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Dec-23 | Planned Option Sale | 8,000 | $10.58 | $84,653.60 | (2%) 422.55K to 414.55K | |
| 17-Nov-23 5:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Nov-23 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 413.4K to 416.4K | |
| 17-Nov-23 5:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Nov-23 | Planned Option Sale | 3,000 | $6.76 | $20,279.70 | (< 1%) 416.4K to 413.4K | |
| 17-Nov-23 5:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-23 | Payment of Exercise | 5,378 | $7.18 | $38,614.00 | (1%) 418.78K to 413.4K | |
| 30-Oct-23 6:26 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Oct-23 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 418.78K to 421.78K | |
| 30-Oct-23 6:26 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Oct-23 | Planned Option Sale | 3,000 | $5.63 | $16,884.90 | (< 1%) 421.78K to 418.78K | |
| 02-Oct-23 10:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Sep-23 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 418.78K to 421.78K | |
| 02-Oct-23 10:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Sep-23 | Planned Option Sale | 3,000 | $7.72 | $23,159.40 | (< 1%) 421.78K to 418.78K | |
| 28-Aug-23 6:04 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 24-Aug-23 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 418.78K to 421.78K | |
| 28-Aug-23 6:04 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 24-Aug-23 | Planned Option Sale | 3,000 | $8.66 | $25,968.30 | (< 1%) 421.78K to 418.78K | |
| 17-Aug-23 6:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Aug-23 | Payment of Exercise | 5,378 | $9.18 | $49,370.00 | (1%) 424.16K to 418.78K | |
| 28-Jul-23 5:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Jul-23 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 2% 424.16K to 432.16K | |
| 28-Jul-23 5:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Jul-23 | Planned Option Sale | 8,000 | $13.62 | $108,994.00 | (2%) 432.16K to 424.16K | |
| 03-Jul-23 3:21 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 29-Jun-23 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 424.16K to 427.16K | |
| 03-Jul-23 3:21 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 29-Jun-23 | Planned Option Sale | 3,000 | $7.49 | $22,470.00 | (< 1%) 427.16K to 424.16K | |
| 02-Jun-23 6:05 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 31-May-23 | Option Exercise | 3,000 | $1.06 | $3,180.00 | < 1% 424.16K to 427.16K | |
| 02-Jun-23 6:05 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 31-May-23 | Planned Option Sale | 3,000 | $8.63 | $25,888.20 | (< 1%) 427.16K to 424.16K | |
| 17-May-23 6:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-May-23 | Payment of Exercise | 5,415 | $5.60 | $30,324.00 | (1%) 427.84K to 422.43K | |
| 27-Feb-23 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 23-Feb-23 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 2% 427.84K to 435.84K | |
| 27-Feb-23 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 23-Feb-23 | Planned Option Sale | 8,000 | $7.82 | $62,540.00 | (2%) 435.84K to 427.84K | |
| 17-Feb-23 5:16 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Feb-23 | Payment of Exercise | 1,603 | $8.44 | $13,529.30 | (< 1%) 429.45K to 427.84K | |
| 03-Feb-23 5:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Feb-23 | Grant | 226,793 | -- | -- | 110% 205.75K to 432.54K | |
| 03-Feb-23 5:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Feb-23 | Payment of Exercise | 3,093 | $8.55 | $26,445.20 | (< 1%) 432.54K to 429.45K | |
| 27-Jan-23 5:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Jan-23 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 4% 203.65K to 211.65K | |
| 27-Jan-23 5:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Jan-23 | Planned Option Sale | 8,000 | $8.07 | $64,547.20 | (4%) 211.65K to 203.65K | |
| 30-Dec-22 5:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 29-Dec-22 | Option Exercise | 8,000 | $1.06 | $8,480.00 | 4% 203.65K to 211.65K |